Both in R&D — Physical & Biological Sciences
iSpecimen vs NRC Health
Over the past year ISPC returned −97.3% and NRC returned +83.6%; their daily moves had a correlation of 0.01.
ISPC −97.3% NRC +83.6%Growth of $1, one year, split-adjusted
| Metric | ISPC | NRC |
|---|---|---|
| Price | $0.8196 | $24.33 |
| Market cap | $2.1M | $516.3M |
| Today | −0.71% | +2.10% |
| 1 month | −24.1% | +19.6% |
| 6 months | −84.8% | +33.5% |
| Year to date | −92.1% | +29.6% |
| 1 year | −97.4% | +85.7% |
| Revenue growth (YoY) | −78.7% | +4.0% |
| Gross margin | 45.2% | 61.7% |
| Net margin | −896.9% | −9.3% |
| P/E (TTM) | — | 93.0× |
| Price / sales | 4.4× | 3.7× |
| Net cash | $4.4M | -$86.7M |
| Dividend yield | — | 2.63% |
| Volatility (60d) | 84.5% | 44.9% |
| Short % of float | 10.4% | 7.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).